中文字幕久久不卡_国产成人二三视频_在线亚洲欧美久草_久久人人超碰九七_亚洲无码欧洲色图

159-2642-3062 027-65317797
服務(wù)熱線(工作日:9:00-17:30)

瀏覽量: 163

  • 產(chǎn)品名稱: Research Grade Idarucizumab ( 艾達賽珠單抗 )
  • 產(chǎn)品貨號: CSD00317
  • 貨期: 現(xiàn)貨
  • 價格與訂購: 2480
  • 數(shù)量:
    庫存: 100
  • 規(guī)格: 100μg
  • 產(chǎn)品信息
  • 如何訂購
    貨號(Catalog No.)
    CSD00317
    通用名INN
    Idarucizumab
    純度(Purity)
    >95%
    濃度( Concentration)
    1mg/ml
    Formulation
    PBS buffer PH7.5
    Source
    CHO cells
    內(nèi)毒素(Endotoxin level)
    Please contact with the lab for this information.
    產(chǎn)品描述(Description)
    Idarucizumab is a humanized monoclonal antibody fragment (Fab) derived from an immunoglobulin G1 isotype molecule that binds to and inactivates the oral anticoagulant dabigatran, thereby reversing its anticoagulant effect. As a direct acting oral anticoagulant (DOAC), one of the risks associated with the use of dabigatran includes bleeding, espeically when given to patients at increased risk (elderly, chronic kidney disease, concomitant NSAID or warfarin use, etc).Approved under the tradename Praxbind (FDA), idarucizumab is indicated for the emergency treatment of dabigatran-associated bleeding in life-threatening or surgically induced situations. Its use is associated with immediate, complete and sustained reversal of the anticoagulant effects of dabigatran.Idarucizumab protein structure can be viewed below, with disulfide bridges at the following points: H22-H95, H149-H205, H225-L-219, L23-L93, L139-L199.
    別名(Alternative names)
    aDabi-Fab,anti-dabigatran,antidote for dabigatran
    靶點;物種(Specificity target name;species)
    MS4A1[Homo sapiens]
    活性研究(體外/體內(nèi)研究)(Activity in vitro)
    Dabigatran selectively and reversibly inhibited human thrombin(Ki: 4.5 nM) as well as thrombin-induced platelet aggregation (IC50: 10 nM), while showing no inhibitory effect on other platelet-stimulating agents. Thrombin generation in platelet-poor plasma (PPP), measured as the endogenous thrombin potential (ETP) was inhibited concentration-dependently (IC50: 0.56 μM). Dabigatran demonstrated concentration-dependent anticoagulant effects in various species in vitro, doubling the activated partial thromboplastin time (aPTT), prothrombin time (PT) and ecarin clotting time (ECT) in human PPP at concentrations of 0.23, 0.83 and 0.18 μM, respectively.
    種類(Species)
    Humanized
    受體鑒定(Receptor identification)
    Fab
    CAS
    1362509-93-0
    存儲條件(Storage)
    Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
    Store at +4°C short term (1-2 weeks).
    Store at -20 °C 12 months.
    Store at -80°C long term.
    Note
    For research use only .
镇安县| 霞浦县| 青神县| 东至县| 黑水县| 安吉县| 翁源县| 榕江县| 大关县| 沙湾县| 长汀县| 绥阳县| 南昌市| 南丰县| 莫力| 项城市| 启东市| 合水县| 华安县| 井陉县| 阳谷县| 无棣县| 高阳县| 增城市| 神木县| 大洼县| 阳泉市| 中西区| 苏尼特右旗| 吉木乃县| 东乡族自治县| 灵丘县| 同仁县| 利津县| 紫阳县| 安龙县| 上虞市| 黔江区| 长武县| 乌兰县| 裕民县|